Hinova Pharmaceuticals, Inc.SSE: 688302

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Hinova Pharmaceuticals, Inc. via Shanghai Stock Exchange

Filed with SSE ·

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Hinova Pharmaceuticals, Inc. on 6ix

Earlier from Hinova Pharmaceuticals

Later from Hinova Pharmaceuticals

All Hinova Pharmaceuticals news releases